Skip to main content
Clinical Trials/CTRI/2022/01/039728
CTRI/2022/01/039728
Active, not recruiting
Phase 2

The Clinical study to evaluate the Rasayana effect of Bharangi Guda IN Post COVID subjects

DR ROOPA 0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B342- Coronavirus infection, unspecifiedHealth Condition 3: J99- Respiratory disorders in diseasesclassified elsewhere
Sponsor
DR ROOPA
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DR ROOPA

Eligibility Criteria

Inclusion Criteria

  • postcovid subject with signs and symptoms of fatigue dyspnoea disturbed sleep cough anorexia and weight loss
  • haemoglobin greater than 8gm/dl
  • upto 1year subjects will be considered for study once he diagnosed as covid19 positive
  • during trial sobjects PTPCR report must be negative
  • subjects who are vaccinated eith 1stdose or both the doses
  • subjects must have either RT\[CR or RAT reports positve to claim that they have exposed to SARS CoV 2 virus

Exclusion Criteria

  • Patient having history of Diabetes mellitus
  • Other Systemic diseases like Sexual transmitted diseases Acquired immuno deficiency virus etc
  • Other postcovid complications like Mucormycosis
  • Pregnant and lactating mothers are excluded from the study

Outcomes

Primary Outcomes

Not specified

Similar Trials